Skip to main content

Atherosclerotic Disease and LDL Greater than 100 - Use of Lipid Lowering Agent

CBE ID
0636
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

The percentage of patients aged 18 and older with a diagnosis of atherosclerotic disease whose most recent LDL-C value is greater than 100 mg/dL and who are taking a lipid lowering agent

    Measure Specs
      General Information
      1.14 Numerator

      Patients with a current fill for a lipid lowering agent

      1.15 Denominator

      Patients with a diagnosis of atherosclerotic disease and whose most recent LDL-C is greater than 100 mg/dL.

      Exclusions

      General exclusions:

      1. Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months
      2. Patients who have been in a skilled nursing facility in the last 3 months
      3. Patients who are terminally ill or in Hospice
      4. Patient or provider feedback indicating allergy, intolerance or other contraindication to lipid lowering therapy anytime in the past

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      ActiveHealth Management
      Steward POC email
                Public Comments